Sitapride-M 50 mg/500 mg Tablet PR

Sitapride-M 50 mg/500 mg Tablet PR is a prescription diabetes medicine that combines sitagliptin 50 mg and metformin 500 mg in each prolonged-release tablet. It belongs to the DPP-4 inhibitor plus biguanide class and is used to help improve blood sugar control in adults with type 2 diabetes. This strength is meant to be used as part of a broader diabetes plan that includes diet, exercise, and regular blood sugar monitoring.

How it works: Sitagliptin helps the body release more insulin after meals and lowers the amount of sugar made by the liver by supporting natural hormone signals. Metformin reduces sugar production in the liver and helps the body use insulin better, while the prolonged-release tablet is designed to release medicine gradually over time.

Sitapride-M 50 mg/500 mg Tablet PR is a specific mid-strength combination tablet, with metformin at 500 mg and sitagliptin at 50 mg in a prolonged-release form. Because there is no other strength in this brand range listed here, this tablet is one fixed option rather than a starter-versus-step-up choice within the brand; a doctor may choose it when a patient needs both medicines in these amounts and a once-daily prolonged-release tablet.

• Type 2 diabetes blood sugar control
• Used with diet and exercise
• May be used alone or with other diabetes medicines when prescribed
• Helps lower fasting and after-meal blood glucose
• Supports long-term glucose management

• Swallow the Sitapride-M 50 mg/500 mg Tablet PR whole with water; do not crush, chew, or split it.
• Take it exactly as prescribed, usually with a meal to reduce stomach upset.
• Take it at the same time each day if your doctor prescribes once-daily use.
• If you miss a dose, take it when you remember unless it is close to the next dose; do not double up.
• Do not change the dose or stop the tablet without medical advice.
• If tablets look different from what you expect, check with your pharmacist before taking them.

Each Sitapride-M 50 mg/500 mg Tablet PR provides sitagliptin 50 mg plus metformin 500 mg. How often it is taken depends on your doctor’s plan; some patients may take it once daily, while others may need a different schedule with total daily doses adjusted to blood sugar goals and kidney function. The maximum daily amount is set by the prescriber, and it should not be increased on your own.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Sitagliptin + Metformin may include:

• Nausea
• Diarrhea
• Stomach upset
• Gas or bloating
• Headache
• Runny nose or upper respiratory symptoms
• Low blood sugar when used with insulin or a sulfonylurea

• Tell your doctor if you have kidney disease, because metformin-containing products may need dose adjustment or may not be appropriate.
• Avoid heavy alcohol use, which can raise the risk of lactic acidosis with metformin.
• Use caution if you have a history of pancreatitis.
• Low blood sugar is more likely if Sitapride-M 50 mg/500 mg Tablet PR is taken with insulin or a sulfonylurea.
• Do not use it to treat type 1 diabetes or diabetic ketoacidosis.
• Report any worsening heart failure symptoms, shortness of breath, or swelling to your clinician.
• If you are having surgery or contrast imaging, ask your doctor whether you need to stop metformin temporarily.

• Alcohol
• Insulin and sulfonylureas such as glimepiride or glipizide
• Iodinated contrast dye used for some CT scans or procedures
• Medicines that affect kidneys or raise dehydration risk, such as certain diuretics
• Strong enzyme/transporter interactions may alter sitagliptin or metformin exposure, so review all prescriptions and supplements with your doctor

Store Sitapride-M 50 mg/500 mg Tablet PR at room temperature in its original strip/box, protected from moisture and out of reach of children.